Glaxo (GSK), Theravance (THRX) Submit UMEC/VI NDA for COPD Patients
Go back to Glaxo (GSK), Theravance (THRX) Submit UMEC/VI NDA for COPD Patients| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 52.41 +0.45 (0.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $51.96 | 52 Week High | $45.58 | |||
| Open | $51.35 | 52 Week Low | $37.82 | |||
| Day High | $52.57 | P/E | N/A | |||
| Day Low | $51.35 | EPS | $0.00 | |||
| Volume | 2,404,769 | |||||
| Theravance, Inc. (NASDAQ: THRX) | Delayed: 4.06 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.06 | 52 Week High | $21.16 | |||
| Open | $0.72 | 52 Week Low | $6.36 | |||
| Day High | $4.06 | P/E | N/A | |||
| Day Low | $4.06 | EPS | $-1.53 | |||
| Volume | 107,542 | |||||
